The tragic stories of healthcare professionals like Dr. Lorna Breen, Dr. Matt Gall, Dr. Mo Brown, Dr. Scott Jolley, Dr. William West Jr., and Tristin Smith, RN illustrate an alarming reality: suicide rates among U.S. healthcare workers have reached crisis levels. The unfortunate truth is that these names could easily broaden to reflect an entire
Health
Primary biliary cholangitis (PBC) is a chronic disease that primarily affects the liver, leading to progressive destruction of the bile ducts and eventual liver failure. The approval of ursodeoxycholic acid (UDCA) in 1997 was a major advance, significantly altering management strategies. Although it reduced the risks associated with liver transplantation and mortality, UDCA is not
Crohn’s disease, a chronic inflammatory bowel disorder, poses a significant challenge for many patients worldwide, particularly those with moderately to severely active forms. Traditional therapies, including conventional biologics, often fall short for a substantial portion of patients. New research surrounding mirikizumab (marketed as Omvoh) sheds light on promising outcomes from recent clinical trials, offering hope
Recent research emerging from France has unveiled a possible connection between the consumption of ultraprocessed foods and the exacerbation of psoriasis. The study, conducted within the expansive NutriNet-Santé cohort, determined that individuals suffering from active psoriasis were more likely to consume higher quantities of ultraprocessed foods, such as sugary sodas and ready-to-eat frozen meals. With
Medicare Advantage (MA) plans, integral to the U.S. healthcare system, are under scrutiny as the Centers for Medicare & Medicaid Services (CMS) unveil a proposed rule aimed at increasing transparency in prior authorization policies. This initiative is part of an ongoing effort by the Biden administration to reform healthcare access under Medicare, ensuring that patients
Meningiomas, tumors that arise from the meninges—the protective membranes covering the brain and spinal cord—are notorious for their varied biological behavior and treatment challenges. The conventional route of treatment often involves surgical removal; however, certain cases, especially those involving larger tumors or unforeseen complications, necessitate a preoperative intervention. One such procedure that has garnered attention
In the intricate realm of healthcare, regulatory dilemmas often emerge as significant obstacles to innovation and patient care. A recent discussion led by Donald Kohn, MD, emphasized the tough choices that medical professionals and regulators face regarding andexanet alfa (Andexxa), a critical bleeding reversal agent. The debate surrounding its full approval underscores an essential tension
Donald Trump’s recent nominations for pivotal public health positions signal a distinct approach to health policy in the United States, shaping the future of the Centers for Disease Control and Prevention (CDC) and the Office of the Surgeon General. Appointing individuals like Dave Weldon, MD, to head the CDC, along with Janette Nesheiwat, MD, as
The announcement of Dr. Marty Makary as the prospective head of the U.S. Food and Drug Administration (FDA) signals a dramatic shift in the agency’s direction under an administration characterized by its controversial health policies and perspectives. President-elect Donald Trump’s endorsement of Makary as a solution to restore trust and efficacy within the FDA raises
Chronic pain has become a pressing public health concern in the United States, affecting a significant portion of the adult population. According to a recent report from the Centers for Disease Control and Prevention (CDC), the prevalence of chronic pain among U.S. adults surged to 24.3% in 2023, marking a notable increase from previous years.